FSSAI launches dedicated licensing window for Ayurveda Aahara products

New Delhi:  The Food Safety and Standards Authority of India (FSSAI), under the Ministry of Health and Family Welfare, has officially launched a dedicated licensing and registration window for Ayurveda Aahara products on its Food Safety Compliance System (FoSCoS) portal. This significant step will enable manufacturers across India to seamlessly apply for licenses to produce and market traditional Ayurvedic foods.

The new ‘Kind of Business’ (KoB) framework for Ayurveda Aahara aims to formalise and streamline the sector, aligning traditional recipes—as documented in authoritative Ayurveda texts—with contemporary food safety and quality standards. This move is designed to boost the food and Ayurveda industries by creating a regulated pathway for these products to reach the market.

This regulation is rooted in the core Ayurvedic principle of personalized nutrition, which tailors diet to an individual’s specific constitution (prakriti). By standardizing these traditional formulations, the FSSAI measure is expected to support the growth of the food and Ayurveda industries. Furthermore, the availability of authentic and regulated Ayurveda Aahara will serve as a critical support for prescribed Ayurvedic treatment plans.

To facilitate a smooth transition for the industry, FSSAI has already published a list of 91 approved Ayurveda Aahara recipes via an order dated 25th July 2025. This provides Food Business Operators with a clear, pre-approved reference for manufacturing products under this new category, ensuring both authenticity and regulatory compliance.

This initiative, developed in close collaboration with the Ministry of Ayush, reflects the Government of India’s commitment to integrating the profound wisdom of Ayurveda with modern food safety practices, thereby benefiting both industry stakeholders and public health.

Related Posts

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

New Delhi: The entry of semaglutide generics in India is ‘stimulating’ market growth and providing a favourable push to Eli Lilly’s blockbuster brand Mounjaro (tirzepatide), said Patrik Jonsson, Executive Vice…

Pak-made illegal cosmetics recovered from Itwari shop

Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert